What change did UBS make to ORA on March 3, 2026?

On March 3, 2026 UBS maintained its **Buy** rating for Ormat Technologies, Inc. (ORA) and lowered its price target to **$143**, reflecting revised forecasts while keeping a positive stance.

How should investors interpret the maintained Buy in the ORA analyst rating?

A maintained Buy indicates UBS still favors ORA longer term but cut the price target due to near-term forecast risk. Investors should weigh the note against company results and sector trends.

Did the UBS note move ORA stock price significantly?

The UBS action corresponded with a modest move of **-0.31% (-$0.33)**, suggesting investors saw the maintained Buy and lower target as a mixed but not surprising update.

What does Meyka AI say about ORA after this rating change?

Meyka AI rates **ORA with a grade of B+** based on benchmark, sector, growth, metrics, and analyst consensus. This grade complements the UBS update but is not financial advice.

Analyst Ratings

UBS Maintains Buy on Ormat Technologies, Inc. (ORA) March 2026

ByDanny Kontos March 4, 2026

On March 3, 2026 UBS maintained its Buy rating on Ormat Technologies, Inc. (ORA) while lowering its price target to $143. This ORA analyst rating keeps UBS positive on the company but reflects reduced near-term upside after model revisions. Investors should note the mixed signal: a continued Buy stance alongside a trimmed forecast.